CYTX
Up on a PR stating they've got FDA approval for additional clinical sites. MC has increased by $38M. Typical biotech operating at a loss. Keep an eye out for a measured move, 50-100% of yesterdays move
CYCC
Delisting play, needs to stay over $1. Not manipulated at all
ARQL
Looks like the stock is running in anticipation of the earnings conference in March. Company has plenty of cash and not much debt. Not the typical trash, just watching for now,
No comments:
Post a Comment